Mild hyperphenylalaninemia: to treat or not to treat
β Scribed by Francjan J. van Spronsen
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 126 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
β¦ Synopsis
One of the issues to be resolved in phenylketonuria is whether patients with mild hyperphenylalaninemia need treatment, or in other words, in what patients treatment needs to be started. Do patients need treatment when phenylalanine concentrations in blood are >360Β ΞΌmol/L or >600Β ΞΌmol/L? This paper reviews the literature on the outcome of untreated patients with mild hyperphenylalaninemia to try to determine whether outcome is normal. The paper concludes that there is, in fact, only one paper that can be used to answer this question. Therefore, the question is whether we may rely on one paper to draw conclusions or whether more research is necessary to determine whether all patients with phenylalanine concentrations >360Β ΞΌmol/L or all patients with phenylalanine concentrations >600Β ΞΌmol/L require treatment.
π SIMILAR VOLUMES
## Background In people who are infected with the hepatitis C virus (HCV), chronic infection often develops and is difficult to eradicate. We sought to determine whether treatment during the acute phase could prevent the development of chronic infection. Methods Between 1998 and 2001, we identifi
There has been a remarkable resurgence of interest recently in the treatment of liver metastases. The reasons for this are twofold. Firstly, improved pre-operative assessment has enabled more careful patient selection and hence better results have been achieved from resectional surgery, and secondly